Research
Lay Science Writing Competition 2024: Evaluating umbilical cord blood transfusion efficacy and safety in neonates
October 17, 2024
The 2024 Lay Science Writing Competition offered in partnership with CBS provides research trainees an opportunity to exercise and enhance their science communication skills. Congratulations to Mahsa Yazdanbakhsh, author of the third prize-winning entry!
Amenorrhea in Women with HIV: Unveiling Key Risk Factors for Menstrual Health
October 8, 2024
New research from the UBC Centre for Blood Research and collaborators throughout UBC, examines the prevalence of early prolonged secondary amenorrhea in women with HIV and its associated biopsychosocial factors.
Keeping honey bee queens healthy through Canadian winters
October 3, 2024
As Canadians prepare for the long winter months ahead, UBC’s Dr. Leonard Foster is working to help another species survive the bitter cold—honey bees.
A novel sequencing panel for somatic hypermutation (SHM) status determination
September 10, 2024
A Next Generation Sequencing (NGS) panel developed by Dr. Aly Karsan’s group in the BC Cancer Research Centre and CBR allows for simultaneous detection of somatic hypermutation status (SHM) and other key clinical variants to inform treatment of Chronic Lymphocytic Leukemia.
UBC research pinpoints how early-life antibiotics turn immunity into allergy
August 21, 2024
Researchers from UBC have shown for the first time how and why the depletion of microbes in a newborn’s gut by antibiotics can lead to lifelong respiratory allergies.
Transforming Transfusion: engineered platelets using lipid nanoparticles
July 9, 2024
A new exciting avenue of transfusion research is being investigated by the Kastrup, Cullis, Jan, and Devine labs at the CBR. They delve into the possibility of genetically modifying platelets to express proteins that may offer greater therapeutic benefits.
Antibiotic Failure – Beyond Antimicrobial Resistance
July 2, 2024
A recent review by the Hancock Lab delves into antimicrobial resistance, with topics that include contributors to antibiotic failure, how these may be alleviated by rapid diagnostics, and alternatives to antibiotics.
Jefferies lab demonstrates potential of a novel cell-based immunotherapy for cancer
May 8, 2024
A new study from the Jefferies lab highlights a promising, novel avenue for cancer immunotherapy using Type 2 innate lymphoid cells.
Familial Alzheimer’s disease transferred via bone marrow transplant in mice
April 10, 2024
In a recent study, Dr. Wilfred Jefferies & Dr. Chaahat Singh show that familial Alzheimer’s disease can be transferred via bone marrow transplant.
Targeting a hitherto enigmatic protein could help to treat people with insulin resistance
April 9, 2024
A new study highlights the CD248 protein as potentially being key in combatting insulin resistance, a core problem in type 2 diabetes.